HB 703 – New Hampshire

Status: Enacted
Year Introduced: 2019
Year Enacted: 2020
Link: http://gencourt.state.nh.us/bill_status/bill_status.aspx?lsr=806&sy=2019&sortoption=&txtsessionyear=2019&txtbillnumber=HB703

Relative to providing notice of the introduction of new high-cost prescription drugs. This bill requires prescription drug manufacturers to provide certain notice to the insurance department if they are introducing a new prescription drug to market at a wholesale acquisition cost that exceeds the threshold set for a specialty drug under the Medicare Part D program.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found